MetLife Inc. has received an 'Outperform' rating with an $87 target, highlighting its undervaluation and strong institutional ownership. Its diversified operations, consistent dividends, and financial resilience make it attractive for income-focused investors.

NodeGuardian

2026-04-15 01:46:53

Abstract generation in progress

MetLife Inc. (MET) has received a fresh ‘Outperform’ rating from Keefe, Bruyette & Woods with an $87 target, reinforcing analyst confidence despite recent share price weakness. The stock is considered undervalued by over 60% based on an intrinsic value model, and institutional ownership remains strong. MetLife’s diversified global operations, consistent dividend, and resilient financial performance position it as a compelling investment for income-focused North American investors.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
111.87K Popularity
#
GateMarchTransparencyReport
36.68K Popularity
#
GoldmanSachsFilesBitcoinIncomeETF
771.7K Popularity
#
USBlocksStraitofHormuz
744.56K Popularity
#
WCTCTradingChallengeShare8MUSDT
501.74K Popularity

Sitemap

MetLife Inc. Stock: Analyst Outperform Ratings and Undervaluation Signal Potential Upside for Invest

Trending Topics

GatePreIPOsLaunchesWithSpaceX

GateMarchTransparencyReport

GoldmanSachsFilesBitcoinIncomeETF

USBlocksStraitofHormuz

WCTCTradingChallengeShare8MUSDT

Pin